Bayer Genuine Aspirin
- Product NDC
- 70264-013
- 11-digit product format
- 702640013
- Labeler code
- 70264
- Product ID
- 70264-013_43cb3193-0671-d065-e063-6394a90afd47
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- R J General Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-07-31
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 70264-013-01 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 70264-013-01 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 70264-013-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 70264-013-01 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 70264-013-01 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 70264-013-01 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bayer Genuine Aspirin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 23daa359-d40f-4f64-81be-6d154f41df9f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70264-013-01 | 2022-12-26 | C162847 | 48780-1 | 9d75b9d0-baa9-f424-e053-dadaa90a57ce | Bayer Genuine Aspirin ® |
| 70264-013-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-baa9-f424-e053-dadaa90a57ce | Bayer Genuine Aspirin ® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70264-013-01 | Bayer Genuine Aspirin | 50 in 1 CARTON | TABLET | 50 | 6 | |
| 70264-013-01 | Bayer Genuine Aspirin | 2 in 1 POUCH | TABLET | 2 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin Low Dose | ASPIRIN | ATLANTIC BIOLOGICALS CORP. | 024c5054-959f-4ea5-a71f-c0e16cc4b90c | 2025-06-24 | Warnings | M013 |
| CHILDRENS ACETAMINOPHEN | CHILDRENS ACETAMINOPHEN ORAL | AARNA USA INC. | 38070d15-2678-4e59-e063-6294a90ab690 | 2025-06-20 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Morning Star OTC | 8502ea21-937d-4b33-a3e0-ffab5dc38cd8 | 2025-06-19 | Warnings | M013 |
| Tylenol PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Morning Star OTC | 6cd07a01-7034-4994-bbd3-bedcdf7d5b83 | 2025-06-19 | Warnings | M013 |
| DRX CHOICE Tension Headache | ACETAMINOPHEN, CAFFEINE | Raritan Pharmaceuticals Inc. | 8a5cb38b-669d-4177-b33b-d73c7ef48d18 | 2025-06-13 | Warnings | M013 |
| good sense childrens pain and fever | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 3777f4fb-d279-199d-e063-6394a90acf36 | 2025-06-13 | Warnings | M013 |
| Aspirina Cafeina | ASPIRIN,CAFFEINE | Bayer HealthCare LLC. | 2e709acc-325a-baca-e063-6394a90a24be | 2025-06-12 | Warnings | M013 |
| Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 696f55b1-536c-40c4-91f7-b572c39220db | 2025-06-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | CVS Pharmacy, Inc. | 6dea9e11-ff99-63c7-e053-2a91aa0a5b54 | 2025-06-10 | Warnings | M013 |
| Children Acetaminophen Oral Solution | ACETAMINOPHEN | MAJOR PHARMACEUTICALS | cfca5147-f390-40bd-8f13-c5b3b8d1c5b0 | 2025-06-09 | Warnings | M013 |
| Aspirin | ASPIRIN | Trifecta Pharmaceuticals USA LLC | 372be427-acbd-c10c-e063-6294a90a572d | 2025-06-09 | Warnings | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | CVS Pharmacy | d6c8118c-bf78-4194-9b14-8de33c3ecdb7 | 2025-06-06 | Warnings | M013 |
| Dolo-NeuroBion | ACETAMINOPHEN | BENARD INDUSTRIES INC | b8310770-84d1-4a6f-8e23-9974947f92f1 | 2025-06-04 | Warnings | M013 |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | Rite Aid Corporation | 69bda7d7-8660-4e8d-b8ac-892a3b1f2124 | 2025-06-03 | Warnings | M013 |
| Kids Pain and Fever | ACETAMINOPHEN | KinderFarms, LLC | fb74e8f9-d72f-4681-90bd-df48364405b5 | 2025-06-01 | Warnings | M013 |
| Pain and Fever Childrens | ACETAMINOPHEN | P & L Development, LLC | b815fcae-8bba-4737-ac10-29a32fb69275 | 2025-05-30 | Warnings | M013 |
| Infants Pain and Fever | ACETAMINOPHEN | KinderFarms, LLC | 81cc4900-226b-4c49-ba9c-5747d2a501b1 | 2025-05-29 | Warnings | M013 |
| good sense pain relief pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Bryant Ranch Prepack | e08a7ab1-4b68-422a-97bd-2c5326633943 | 2025-05-29 | Warnings | M013 |
| Acetaminophen Gelcaps | ACETAMINOPHEN | Kroger | 30d3f2d0-da35-7f6f-e063-6294a90a9c22 | 2025-05-23 | Warnings | M013 |
| Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | fcffa7e6-145c-6bc0-e053-6294a90a4751 | 2025-05-23 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | BAYER Aspirin 325 MG Oral Tablet | PSN | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | aspirin 325 MG Oral Tablet [Bayer Aspirin] | SBD | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 212033 | ASA 325 MG Oral Tablet | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | ASA 325 MG Oral Tablet [Bayer Aspirin] | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | Bayer Aspirin 325 MG Oral Tablet | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70264-013-01 | 70264001301 | 50 POUCH in 1 CARTON (70264-013-01) / 2 TABLET in 1 POUCH | 50 pouch | 2014-07-31 | 0000-00-00 | No | No | Current |